Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €61.30 | €80.00 | 30.506% |
| Novartis AG ADR | 1 | 0 | 0 | 0 | €91.00 | - | - |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Bio-Techne Corp. | 8 | 0 | 0 | 0 | €58.50 | €75.80 | 29.573% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €73.50 | €79.00 | 7.483% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €212.30 | €247.61 | 16.631% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €187.75 | - | - |
| Lightpath Techs A | 3 | 0 | 0 | 0 | €1.32 | €2.78 | 110.879% |
| Cutera Inc. | 1 | 0 | 0 | 0 | €1.99 | €3.00 | 51.057% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.94 | €26.01 | 18.534% |
| Vitrolife AB | 3 | 0 | 0 | 0 | €13.96 | - | - |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €24.00 | €26.58 | 10.756% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Celldex Therapeutics | 9 | 1 | 0 | 0 | €34.00 | €51.20 | 50.581% |
| Repligen Corp. | 12 | 0 | 0 | 0 | €154.50 | €182.96 | 18.421% |
| Lemaitre Vascular Inc | 1 | 0 | 0 | 0 | €59.00 | - | - |
| ShockWave Medical Inc | 1 | 0 | 0 | 0 | €306.80 | - | - |
| Integer Hldg | 1 | 0 | 0 | 0 | €117.00 | - | - |
| Viking Therapeutics Inc | 4 | 1 | 0 | 1 | €69.44 | €140.00 | 101.613% |
| Immunogen Inc. | 6 | 0 | 0 | 0 | €28.97 | - | - |
| Maternus-Kliniken AG | 1 | 0 | 0 | 0 | €1.81 | €1.65 | -8.840% |
| Rigel Pharmaceutical Inc. | 9 | 0 | 0 | 0 | €1.02 | €13.74 | 1243.324% |
| Baxter International | 3 | 0 | 0 | 0 | €37.51 | €48.16 | 28.395% |
| Teleflex Inc. | 10 | 0 | 0 | 0 | €195.00 | €247.18 | 26.759% |
| Galmed Pharmaceuticals Ltd. | 4 | 0 | 0 | 0 | €0.37 | €61.56 | 16628.016% |